|1.||Silman, Alan J: 2 articles (06/2007 - 01/2006)|
|2.||Thomson, Wendy: 2 articles (06/2007 - 01/2006)|
|3.||Wang, Gang: 2 articles (06/2006 - 08/2005)|
|4.||Dong, Chun-Hua: 1 article (01/2015)|
|5.||Goss, Paul E: 1 article (01/2015)|
|6.||Ura, Somei: 1 article (01/2015)|
|7.||King, Karen S: 1 article (01/2015)|
|8.||Byrne, Julie: 1 article (01/2015)|
|9.||Tomimori, Jane: 1 article (01/2015)|
|10.||Spraggs, Colin F: 1 article (01/2015)|
10/01/2008 - "The HLA-DRB1*07 allele was significantly more common in HCV patients (33.3 vs 12.1%) than in controls (Pc = 0.0039), suggesting that the HLA-DRB1*07 allele is associated with chronic HCV infection."
01/01/2008 - "HLA-DRB1*07, is associated with the susceptibility of the infants to intrauterine HBV infection."
04/01/2004 - "Analyses of polymerase chain reaction (PCR)-based genotyping data from 164 North American adolescents vaccinated with recombinant HBV products confirmed that HLA-DRB1*07 (relative odds [RO] = 5.18, P <.0001) and human immunodeficiency virus type 1 (HIV-1) infection (RO = 3.91, P <.001) were both associated with nonresponse to full-dose vaccination. "
08/01/2014 - "The results of the present study also showed a significant association between possession of HLA-DRB1*07 allele in kidney transplant recipients and hepatitis C virus infection (P = 0.009). "
09/28/2005 - "Compared with other HLA-DRB1 alleles, HLA-DRB1*06, DRB1*08, and DRB1*16 may be associated with chronicity of HBV infection, HLA-DRB1*07 with protection against HBV infection, and HLA-DRB1*14 allele may be associated with a high rate of the response of CHB patients to IFN treatment. "
|2.||Hemophilia A (Haemophilia)
01/01/2008 - "The frequency difference was found to be statistically significant when comparing HLA alleles distribution in the sample of hemophilia patients who naturally cleared HCV (n=18) and in the control group (n=60) (corresponding frequency of HLA-DRB1*07 allele - 4 (11.11%) and 9 (1.67%); OR=7.38; P<0.05). "
05/01/1999 - "Patients with type 2 autoimmune hepatitis have different HLA frequencies than patients with type 1 disease and HLA-DRB1*07 may be an important risk factor. "
01/01/2010 - "HLA-DRB1*07 and HLA-DRB1*15 may be susceptibility alleles for occurrence of autoimmune hepatitis type 2. HLA-DRB1*12 association with AIH in patients triggered by hepatitis A needs further studies."
03/01/2006 - "Autoimmune hepatitis type 2 (AIH-2), a severe juvenile liver disorder of unknown etiology and pathogenesis, is characterized by liver-kidney microsomal antibody type 1 targeting cytochrome P450IID6 (CYP2D6) and is associated to HLA DRB1*07. "
11/01/2011 - "Comparisons of clinical features of HLA-DRB1*07 positive and negative vitiligo patients in Chinese Han population."
06/01/2009 - "Furthermore, we also found suggestive epistatic effect between rs2269577 and HLA-DRB1*07 allele on the development of vitiligo (p = 0.033). "
01/01/2012 - "Our studies have identified three specific alleles, HLA-A*33:01, HLA-B*44:03, and HLA-DRB1*07:01, to be significantly increased in vitiligo patients as compared with controls in both the initial study on North Indians (N=1,404) and the replication study in Gujarat (N=355) cases, establishing their positive association with vitiligo. "
|5.||Hepatitis A (Hepatitis, Infectious)
|1.||HLA-DRB1 antigen (HLA DRB1)
|2.||HLA-B Antigens (HLA-B)
|3.||HLA-A Antigens (HLA-A)
|6.||Keratin-17 (Keratin 17)
|7.||Cytochrome P-450 CYP2D6 (CYP2D6)
|8.||T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)
|9.||HLA-C Antigens (HLA-C)
|10.||HLA-DR Antigens (HLA-DR)
|1.||Transplantation (Transplant Recipients)